2026 DDW Review

Lexington, KY US
August 22, 2026

Registration

Pre-registration is required. Participants should select the Register icon to enroll in the activity. Once registration is complete, the Start Activity icon will appear, and a registration confirmation will be sent to the email address associated with the participant's CECentral account.

Participants should return to the activity following the conference to complete the required evaluation and claim continuing education credit.

 

This Continuing Medical Education (CME) seminar provides a comprehensive synopsis of the groundbreaking clinical updates and research presented at Digestive Disease Week (DDW) in Chicago, Illinois. Recognizing the rapid pace of advancement in gastroenterology and hepatology, the University of Kentucky GI department has secured the official conference proceedings to bring this vital knowledge directly to regional healthcare providers.

Six expert faculty members from the UK Division of Gastroenterology and Hepatology will synthesize and present key takeaways from the premier global GI conference. This seminar is specifically designed to bridge educational gaps for clinicians who were unable to travel to the annual meeting, as well as past attendees seeking to catch up on critical parallel sessions they may have missed.

Target Audience

Physicians and APP’s

Learning Objectives

Upon completion of this conference, participants will be able to:

  • Summarize practice-relevant advances in gastroenterology, hepatology, and endoscopy presented at DDW 2026.
  • Evaluate emerging DDW 2026 evidence for its relevance to diagnostic, therapeutic, and disease-management decisions across diverse patient populations.
  • Apply current evidence, guideline updates, technologies, and therapeutic advances to patient-centered gastroenterology and hepatology practice.

Course summary

Available credit: 
  • 4.50 AMA PRA Category 1 Credit

    In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.

    This Live activity is designated for a maximum of 4.50 AMA PRA Category 1 Credit™. Physicians should claim only credit commensurate with the extent of their participation in the activity. 

  • 4.50 AMA PRA Category 1 Credit™ Participation

    In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.

    This Live activity is designated for a maximum of 4.50 AMA PRA Category 1 Credit™ Participation. Learners should claim only credit commensurate with the extent of their participation in the activity.

  • 4.50 ANCC (UK Healthcare CECentral)

    In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.

    The maximum number of hours awarded for this Continuing Nursing Education activity is 4.50 nursing contact hour(s).

Course opens: 
08/12/2026
Course expires: 
10/21/2026
Event starts: 
08/22/2026 - 7:30am EDT
Event ends: 
08/22/2026 - 1:30pm EDT
Rating: 
0

DDW 2026 Review

Activity Overview

The DDW 2026 Review will provide healthcare professionals with timely updates and clinical insights from Digestive Disease Week (DDW) 2026. Faculty from the University of Kentucky will review emerging evidence, evolving guidelines, and advances relevant to the diagnosis and management of gastrointestinal and hepatobiliary conditions.

Topics will include emerging therapies and real-world evidence in inflammatory bowel disease, MASH, primary biliary cholangitis and celiac disease, colitides beyond ulcerative colitis and Crohn disease, pancreaticobiliary updates, and the evolving role of artificial intelligence in gastroenterology.

Date and Time

Saturday, August 22, 2026
7:30 AM – 1:30 PM

Location

Malone’s Prime Events & Reception
3373 Tates Creek Rd.
Lexington, KY 40502

Agenda

7:30 AM – 8:00 AM
Breakfast

8:00 AM – 8:45 AM
Dual Biologics, Novel Peptides, and Real-World Evidence: The Expanding IBD Arsenal — The Pitch
Courtney Perry, DO
Associate Professor, University of Kentucky

8:45 AM – 9:30 AM
MASH in the Incretin Era: DDW Highlights and the Next Therapeutic Target
Nimish Thakral, MBBS
Assistant Professor, University of Kentucky

9:30 AM – 10:15 AM
Deciphering 2026 AGA Guidelines: Direct Impact on Point-of-Care Decisions in PBC and Asymptomatic Celiac Disease
Venkata Rajesh Konjeti, MD, FACP, DABOM
Assistant Professor, University of Kentucky

10:15 AM – 10:30 AM
Break

10:30 AM – 11:15 AM
DDW GI Potpourri: Colitides Beyond UC and Crohn
Deborah Flomenhoft, MD
Professor, University of Kentucky

11:15 AM – 12:00 PM
PancreaticoBiliary Updates
Kshitij Thakur, MD
Assistant Professor, University of Kentucky

12:00 PM – 12:45 PM
Lunch Break

12:45 PM – 1:30 PM
Artificial Intelligence in Gastroenterology: Current Challenges, Critical Evidence, and Clinical Translation
Bahaaeldeen Ismail, MD
Associate Professor, University of Kentucky

Malone's Prime Events & Reception
3373 Tates Creek Road
Lexington, KY 40502
United States
Planner(s)

Venkata Rajesh Konjeti, MD FACP DABOM

has no relevant financial relationships to disclose at this time.
Speaker(s)

Yazan Abu Omar, MD

has no relevant financial relationships to disclose at this time.

Blake Bentley, MD

has no relevant financial relationships to disclose at this time.

Deborah Flomenhoft, MD

has a financial relationship (Professional Services) with Abbvie;.
has a financial relationship (Professional Services) with Janssen;.
has a financial relationship (Professional Services) with Janssen;.

Bahaaeldeen Ismail, MD, M.Sc.

has no relevant financial relationships to disclose at this time.

Venkata Rajesh Konjeti, MD FACP DABOM

has no relevant financial relationships to disclose at this time.

Courtney Perry, DO MS

has a financial relationship (Professional Services) with ABBVIE;.

Nimish Thakral, MD

has no relevant financial relationships to disclose at this time.

Kshitij Thakur, MD, MSc, FACP

has no relevant financial relationships to disclose at this time.

In support of improving patient care, University of Kentucky HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

AMA

This live activity is designated for a maximum of 4.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

AMA PRA Category 1 Credit™ Participation

In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.

This Live activity is designated for a maximum of 4.50 AMA PRA Category 1 Credit™ Participation. Learners should claim only credit commensurate with the extent of their participation in the activity.

ANCC credit:

The maximum number of hours awarded for this Continuing Nursing Education activity is 4.5 nursing contact hour(s).

Available Credit

  • 4.50 AMA PRA Category 1 Credit

    In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.

    This Live activity is designated for a maximum of 4.50 AMA PRA Category 1 Credit™. Physicians should claim only credit commensurate with the extent of their participation in the activity. 

  • 4.50 AMA PRA Category 1 Credit™ Participation

    In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.

    This Live activity is designated for a maximum of 4.50 AMA PRA Category 1 Credit™ Participation. Learners should claim only credit commensurate with the extent of their participation in the activity.

  • 4.50 ANCC (UK Healthcare CECentral)

    In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.

    The maximum number of hours awarded for this Continuing Nursing Education activity is 4.50 nursing contact hour(s).

Please login or register to take this course.